TOP TIERMARKET NEWSWIRE
News & sentiment

MONOPAR THERAPEUTICS Equity (MNPR) — News & AI sentiment

MONOPAR THERAPEUTICS Equity (MNPR) news roundup. 6 stories aggregated over the last 30 days. Average 30-day sentiment is 62.2/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
6
avg sentiment 62.2/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

Latest stories on MNPR

H.C. Wainwright raises Monopar stock price target to $125 on NDA filing
Investing.com Analyst Ratings61 · neutralanalyst
Jul 23
Jul 22
Monopar Therapeutics (MNPR) files 8-K
SEC 8-K50 · neutralgeneral
Jul 22
Jul 22
Jul 20
Jul 17
Jul 3
Jun 30
Monopar Therapeutics (MNPR) files 8-K
SEC 8-K50 · neutralgeneral
Jun 30
Jun 30
Jun 26
Monopar Therapeutics (MNPR) files 8-K
SEC 8-K50 · neutralgeneral
Jun 26
Jun 26
Monopar Therapeutics (MNPR) files 8-K
SEC 8-K50 · neutralgeneral
Jun 23
Jun 1
May 19
Open MNPR in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →